Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **vascular endothelial growth factor receptor (VEGFR) tyrosine kinase domain** is an intracellular catalytic region present in VEGFR-1, VEGFR-2, and VEGFR-3, which are receptor tyrosine kinases crucial for mediating vascular endothelial growth factor (VEGF)-driven signaling. This domain typically exists in a ‘split’ configuration, with N- and C-terminal lobes separated by an insert sequence, and contains key motifs—such as a glycine-rich ATP-binding loop, a catalytic HRD motif, and an activation loop with a DFG motif—that regulate kinase activity. The kinase domain is essential for initiating downstream signaling that controls endothelial cell proliferation, survival, migration, and blood vessel formation. Inhibitors targeting this domain block ATP binding and receptor autophosphorylation, providing a key strategy in anti-angiogenic therapies for cancers and other diseases characterized by pathological angiogenesis[1][2][3]. Note: To reference a true canonical target, use the full receptor such as "Vascular endothelial growth factor receptor 2 (VEGFR-2, KDR)" for structured ontologies. The tyrosine kinase domain itself is an essential region but not separately drugged outside the context of the full protein.
Inhibition of ATP binding at the kinase domain to block receptor phosphorylation and downstream signaling Allosteric inhibition of kinase activity Prevention of receptor activation and dimerization
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial growth factor receptor tyrosine kinase domain (VEGFR TK domain).